Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 3/20 | 0.71 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.71 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.71 |
| ▸ | HRH1 | P35367 | 1/20 | 0.71 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.67 |
| ▸ | RECQL | P46063 | 1/20 | 0.67 |
| ▸ | SLC22A16 | Q86VW1 | 1/20 | 0.61 |
| ▸ | CPT2 | P23786 | 2/20 | 0.57 |
| ▸ | CPT1A | P50416 | 2/20 | 0.57 |
| ▸ | SLC25A20 | O43772 | 3/20 | 0.56 |
| ▸ | TP53 | P04637 | 2/20 | 0.56 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.56 |
| ▸ | TSHR | P16473 | 2/20 | 0.56 |
| ▸ | SLC6A5 | Q9Y345 | 2/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.56 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.56 |
| ▸ | MAPT | P10636 | 1/20 | 0.56 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.56 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.56 |
| ▸ | THPO | P40225 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4256715 | 1.00 | MEN1 (0.71) | MEN1KMT2ACYP1A2HRH1CYP2C19 | |
| SCHEMBL17629809 | 1.00 | MEN1 (0.71) | MEN1KMT2ACYP1A2HRH1CYP2C19 | |
| SCHEMBL8767045 | 0.92 | MEN1 (0.62) | MEN1KMT2ACYP1A2HRH1CYP2C19 | |
| SCHEMBL26797580 | 0.92 | MEN1 (0.62) | MEN1KMT2ACYP1A2HRH1CYP2C19 | |
| SCHEMBL26797583 | 0.92 | MEN1 (0.62) | MEN1KMT2ACYP1A2HRH1CYP2C19 | |
| Cadaverine Tartrate SCHEMBL7526527 | 0.89 | MEN1 (0.59) | MEN1KMT2ACYP1A2HRH1CYP2C19 | |
| SCHEMBL1830071 | 0.87 | MEN1 (0.57) | MEN1KMT2ACYP1A2HRH1CYP2C19 | |
| SCHEMBL28171779 | 0.87 | MEN1 (0.67) | MEN1KMT2ACYP1A2HRH1CYP2C19 | |
| SCHEMBL7031982 | 0.87 | MEN1 (0.67) | MEN1KMT2ACYP1A2HRH1CYP2C19 | |
| SCHEMBL2994007 | 0.85 | MEN1 (0.65) | MEN1KMT2ACYP1A2HRH1CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101317817-A | External slimming coating agent | ZHONGHUA YUAN (CN) | 2008-12-10 | — | — | CN | claimed |
| WO-2024058984-A2 | METHODS AND USES OF MICROBIOME COMPOSITIONS, COMPONENTS, OR METABOLITES FOR TREATING INSULIN-ASSOCIATED DISEASES | MarvelBiome, Inc. (US) | 2024-03-21 | — | — | WO | disclosed |
| WO-2023038450-A1 | PHARMACEUTICAL COMPOSITION COMPRISING LARGE PHYSIOLOGICALLY ACTIVE SUBSTANCE AND EXCIPIENT | (주)디앤디파마텍 | 2023-03-16 | — | — | WO | disclosed |
| EP-3694646-A1 | A STREAMLINED METHOD FOR ANALYTICAL VALIDATION OF BIOCHEMICALS DETECTED USING AN UNTARGETED MASS-SPECTROMETRY PLATFORM | Metabolon, Inc. (US) | 2020-08-19 | — | — | EP | disclosed |
| WO-2019074757-A1 | A STREAMLINED METHOD FOR ANALYTICAL VALIDATION OF BIOCHEMICALS DETECTED USING AN UNTARGETED MASS-SPECTROMETRY PLATFORM | METABOLON, INC. (US) | 2019-04-18 | — | — | WO | disclosed |
| US-20180064154-A9 | MANAGEMENT OF PROPIONATE METABOLISM DISORDERS | MORTON D HOLMES (US) | 2018-03-08 | — | — | US | disclosed |
| US-9662344-B2 | Carnitine retention | THE UNIVERSITY OF NOTTINGHAM (GB) | 2017-05-30 | — | — | US | disclosed |
| US-20170055562-A1 | MANAGEMENT OF PROPIONATE METABOLISM DISORDERS | MORTON D HOLMES (US) | 2017-03-02 | — | — | US | disclosed |
| EP-3094968-A1 | METABOLIC SCREENING FOR GESTATIONAL DIABETES | The Regents of The University of California (US) | 2016-11-23 | — | — | EP | disclosed |
| WO-2015109116-A1 | METABOLIC SCREENING FOR GESTATIONAL DIABETES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2015-07-23 | — | — | WO | disclosed |
| WO-2004082674-A1 | CARNITINE RETENTION | THE UNIVERSITY OF NOTTINGHAM (GB) | 2004-09-30 | — | — | WO | disclosed |
| US-20040058947-A1 | Composition for the prevention or treatment of learning disorders in children suffering from attention deficit/hyperactive disorder | SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. (IT) | 2004-03-25 | — | — | US | disclosed |
| CN-1447680-A | Local release system of micronutrients and application thereof | NIADYNE CORP (US) | 2003-10-08 | — | — | CN | disclosed |
| EP-1272157-A2 | TOPICAL MICRONUTRIENT DELIVERY SYSTEM AND USES THEREOF | Niadyne Corporation (US) | 2003-01-08 | — | — | EP | disclosed |
| WO-2001078660-A2 | TOPICAL MICRONUTRIENT DELIVERY SYSTEM AND USES THEREOF | NIADYNE CORPORATION (US) | 2001-10-25 | — | — | WO | disclosed |
| EP-0951218-A1 | CARNITINE-SUPPLEMENTED DIETS FOR GESTATING AND LACTATING SWINE | KANSAS STATE UNIVERSITY RESEARCH FOUNDATION (US) | 1999-10-27 | — | — | EP | disclosed |
| WO-1998024328-A1 | CARNITINE-SUPPLEMENTED DIETS FOR GESTATING AND LACTATING SWINE | KANSAS STATE UNIVERSITY RESEARCH FOUNDATION (US) | 1998-06-11 | — | — | WO | disclosed |
| US-5238838-A | Hydrolysis catalysts converting L-carnitine amide to L-carnitine; stereospecific | DEGUSSA AKTIENGESELLSCHAFT (DE) | 1993-08-24 | — | — | US | disclosed |
| US-4362719-A | INSULIN, MIXTURES | CAVAZZA CLAUDIO | 1982-12-07 | — | — | US | disclosed |
| US-4272549-A | CARNITINE | CAVAZZA CLAUDIO | 1981-06-09 | — | — | US | disclosed |